State University of New York - Upstate Medical University

• A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

  Collaborator, Phase 2, Recruiting, 55 people, 3 Aug 2026

• NCT07189897

  Collaborator, Phase 4, Recruiting, 76 people, 24 Sept 2025

• NCT06370442

  Phase 3, Status unknown, 60 people, 17 Apr 2024

• NCT06217302

  Collaborator, Phase 3, Recruiting, 150 people, 22 Jan 2024

• NCT04736953

  Phase 2, Not yet recruiting, 220 people, 3 Feb 2021

• NCT02619448

  Early phase 1, Status unknown, 12 people, 2 Dec 2015

• NCT02564471

  Phase 4, Completed, 103 people, 30 Sept 2015

• NCT01745588

  Collaborator, Phase 2, Completed, 23 people, 10 Dec 2012

• NCT01738815

  Early phase 1, Completed, 43 people, 30 Nov 2012

• NCT01257581

  Collaborator, Phase 2, Completed, 60 people, 9 Dec 2010

• NCT00818389

  Collaborator, Phase 2/3, Terminated, 84 people, 7 Jan 2009

• NCT00779194

  Phase 2, Completed, 99 people, 24 Oct 2008

• NCT00775476

  Phase 2, Active, not recruiting, 290 people, 20 Oct 2008

• NCT00727103

  Phase 4, Completed, 10 people, 1 Aug 2008

• NCT00411398

  Phase 3, Completed, 15 people, 14 Dec 2006

• NCT00328809

  Phase 4, Withdrawn, 0 people, 22 May 2006

• NCT00003555

  Phase 1, Completed, 20 people, 16 Aug 2004

Sources: clinicaltrials.gov